Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
TLN-372 in Advanced KRAS Mutant Solid Tumors
for
KRAS Mutant Solid Tumors
Location: Boston MA, New York NY, Toronto, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07204340
Phase 1, Recruiting
Evaluation of a Neural-Controlled Powered Prosthesis Across Diverse Real-World Tasks
for
Transfemoral Amputation
Location: Cambridge MA
Sponsor: Massachusetts Institute of Technology
Sex: All
Age: 18 - 70
Code: NCT07204912
Recruiting
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
for
Lymphocytic Leukemia
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT03219450
Phase 1, Recruiting
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
for
Graft Versus Host Disease (cGvHD)
Location: Boston MA
Sponsor: Sarah Nikiforow, MD
Sex: All
Age: 2+
Code: NCT06991361
Phase 1, Recruiting
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry
for
Systemic Lupus Erythematosus
Location: Waltham MA
Sponsor: CorEvitas
Sex: All
Age: 18+
Code: NCT06804057
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
for
Non Hodgkin Lymphoma, Richter Transformation, Multiple Myeloma,
Location: Boston MA, Chapel Hill NC, Columbus OH, Cincinnati OH,
Sponsor: Newave Pharmaceutical Inc
Sex: All
Age: 13+
Code: NCT04771572
Phase 1, Recruiting
At Home Wearable Sensors and Smartphone for Stroke Survivors With Upper Limb Motor Challenges.
for
Stroke
Location: Charlestown MA
Sponsor: Spaulding Rehabilitation Hospital
Sex: All
Age: 18 - 70+
Code: NCT06787729
Recruiting
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
for
Non-obstructive Hypertrophic Cardiomyopathy
Location: Boston MA, Burlington MA, New York NY, Philadelphia PA,
Sponsor: Imbria Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07023614
Phase 2, Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Location: Boston MA, New York NY, Ann Arbor MI, Nashville TN,
Sponsor: Remix Therapeutics
Sex: All
Age: 18+
Code: NCT06118086
Phase 1, Phase 2, Recruiting
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Boston MA, Burlington MA, Peabody MA, Waterford CT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06769126
Phase 2, Recruiting
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Boston MA, New York NY, Philadelphia PA, Detroit MI,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT04590326
Phase 1, Phase 2, Recruiting
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Location: Boston MA, Hackensack NJ, Philadelphia PA, Fairfax VA,
Sponsor: NiKang Therapeutics, Inc.
Sex: All
Age: 19+
Code: NCT06586957
Phase 1, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Location: Boston MA, New York NY, Philadelphia PA, Ottawa,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05384626
Phase 1, Phase 2, Recruiting
The PREDICT Registry:
for
DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Location: Boston MA, Mineola NY, Lake Success NY, New York NY,
Sponsor: PreludeDx
Sex: Female
Age: 30 - 70+
Code: NCT03448926
Recruiting
Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism
for
Autism Spectrum Disorder
Location: Charlestown MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18 - 60
Code: NCT03827941
Recruiting
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Boston MA, Shirley NY, New Haven CT, New York NY,